176 related articles for article (PubMed ID: 32125773)
1. Reprogramming fibroblasts and peripheral blood cells from a C9ORF72 patient: A proof-of-principle study.
Bardelli D; Sassone F; Colombrita C; Volpe C; Gumina V; Peverelli S; Catusi I; Ratti A; Silani V; Bossolasco P
J Cell Mol Med; 2020 Apr; 24(7):4051-4060. PubMed ID: 32125773
[TBL] [Abstract][Full Text] [Related]
2. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
[TBL] [Abstract][Full Text] [Related]
4. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
5. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
[TBL] [Abstract][Full Text] [Related]
6. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology.
Zhao C; Devlin AC; Chouhan AK; Selvaraj BT; Stavrou M; Burr K; Brivio V; He X; Mehta AR; Story D; Shaw CE; Dando O; Hardingham GE; Miles GB; Chandran S
Glia; 2020 May; 68(5):1046-1064. PubMed ID: 31841614
[TBL] [Abstract][Full Text] [Related]
7. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD.
Dafinca R; Barbagallo P; Farrimond L; Candalija A; Scaber J; Ababneh NA; Sathyaprakash C; Vowles J; Cowley SA; Talbot K
Stem Cell Reports; 2020 May; 14(5):892-908. PubMed ID: 32330447
[TBL] [Abstract][Full Text] [Related]
8. Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins.
Abo-Rady M; Kalmbach N; Pal A; Schludi C; Janosch A; Richter T; Freitag P; Bickle M; Kahlert AK; Petri S; Stefanov S; Glass H; Staege S; Just W; Bhatnagar R; Edbauer D; Hermann A; Wegner F; Sterneckert JL
Stem Cell Reports; 2020 Mar; 14(3):390-405. PubMed ID: 32084385
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis.
Mehta AR; Gregory JM; Dando O; Carter RN; Burr K; Nanda J; Story D; McDade K; Smith C; Morton NM; Mahad DJ; Hardingham GE; Chandran S; Selvaraj BT
Acta Neuropathol; 2021 Feb; 141(2):257-279. PubMed ID: 33398403
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene.
Ruotolo G; D'Anzi A; Casamassa A; Mazzoni M; Ferrari D; Lombardi I; Carletti RM; D'Asdia C; Torrente I; Frezza K; Lattante S; Sabatelli M; Pennuto M; Vescovi AL; Rosati J
Stem Cell Res; 2024 Jun; 77():103412. PubMed ID: 38613988
[TBL] [Abstract][Full Text] [Related]
11. CGG repeat expansion in LRP12 in amyotrophic lateral sclerosis.
Kume K; Kurashige T; Muguruma K; Morino H; Tada Y; Kikumoto M; Miyamoto T; Akutsu SN; Matsuda Y; Matsuura S; Nakamori M; Nishiyama A; Izumi R; Niihori T; Ogasawara M; Eura N; Kato T; Yokomura M; Nakayama Y; Ito H; Nakamura M; Saito K; Riku Y; Iwasaki Y; Maruyama H; Aoki Y; Nishino I; Izumi Y; Aoki M; Kawakami H
Am J Hum Genet; 2023 Jul; 110(7):1086-1097. PubMed ID: 37339631
[TBL] [Abstract][Full Text] [Related]
12.
Lynch E; Semrad T; Belsito VS; FitzGibbons C; Reilly M; Hayakawa K; Suzuki M
Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31439573
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity.
Birger A; Ben-Dor I; Ottolenghi M; Turetsky T; Gil Y; Sweetat S; Perez L; Belzer V; Casden N; Steiner D; Izrael M; Galun E; Feldman E; Behar O; Reubinoff B
EBioMedicine; 2019 Dec; 50():274-289. PubMed ID: 31787569
[TBL] [Abstract][Full Text] [Related]
14. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
[TBL] [Abstract][Full Text] [Related]
15. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
17. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
[TBL] [Abstract][Full Text] [Related]
19. C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.
Esanov R; Belle KC; van Blitterswijk M; Belzil VV; Rademakers R; Dickson DW; Petrucelli L; Boylan KB; Dykxhoorn DM; Wuu J; Benatar M; Wahlestedt C; Zeier Z
Exp Neurol; 2016 Mar; 277():171-177. PubMed ID: 26746986
[TBL] [Abstract][Full Text] [Related]
20. [ALS disease modeling and drug screening using patient-specific iPS cells].
Egawa N; Inoue H
Rinsho Shinkeigaku; 2013; 53(11):1020-2. PubMed ID: 24291866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
